image
Gain Therapeutics, Inc. GANX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.845
5.73 %
$ 47.1 M
Market Cap
-1.63
P/E
BALANCE SHEET
18.6 M ASSETS
-22.78%
Growth Rates
1Year -22.78%
3Years 24.67%
5Years 87.10%
7Years 0.00%
10Years 0.00%
6.03 M LIABILITIES
15.54%
Growth Rates
1Year 15.54%
3Years 21.02%
5Years 27.89%
7Years 0.00%
10Years 0.00%
12.6 M EQUITY
-33.38%
Growth Rates
1Year -33.38%
3Years 26.58%
5Years 72.40%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Gain Therapeutics, Inc.
image
Current Assets 17.8 M
Cash & Short-Term Investments 16.8 M
Receivables 243 K
Other Current Assets 742 K
Non-Current Assets 830 K
Long-Term Investments 0
PP&E 585 K
Other Non-Current Assets 245 K
Current Liabilities 4.95 M
Accounts Payable 1.32 M
Short-Term Debt 348 K
Other Current Liabilities 3.28 M
Non-Current Liabilities 1.08 M
Long-Term Debt 679 K
Other Non-Current Liabilities 402 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 11.8 7.3 36.9 7.5 0.3 0.4
Short Term Investments 5.0 12.8 0 0 0 0
Receivables 0.2 0.1 0.1 66.6 K 44.9 K 0
Inventory 0 0 0 1.4 31.5 K 0
Other Current Assets 0.1 0.4 0.3 71 K 0 93.9 K
Total Current Assets 17.8 21.1 37.7 9.0 0.4 0.5
PP&E 0.6 0.8 1.0 0.6 0.2 0.3
Intangible Assets 0.2 0.2 0.2 0 0 0
Goodwill 0 0 0 0 0 0
Long Term Investments 0 1.9 31.3 K 0 10.4 K 0
Other Long Term Assets 51.9 K 48.3 K 53.4 K 63.8 K 1.03 K 11.2 K
Other Assets 0 0 0 0 0 0
Total Assets 18.6 24.1 39.0 9.6 0.7 0.8
LIABILITIES
Accounts Payable 1.3 1.6 0.6 1.0 0.2 0.1
Short Term Debt 0.3 0.3 0.5 0.1 0.1 97.6 K
Other Current Liabilities 2.1 2.0 1.2 0.8 0.3 0.3
Total Current Liabilities 4.9 4.1 2.6 2.1 0.9 0.5
Long Term Debt 0.7 0.9 1.3 1.1 98.8 K 1.2
Deferred Tax Income 0 0 0 0 0 0
Other Liabilities 0.3 0.2 0.3 0.2 0.1 24 K
Total Liabilities 6.0 5.2 4.2 3.4 1.1 1.8
EQUITY
Common Stock 1.62 K 1.19 K 1.19 K 402 225 225
Retained Earnings (60.8) (38.5) (20.9) (7.0) (3.5) (1.3)
Other Accumulative Comprehensive Income/Loss 0.2 35.6 K 90.6 K (0.2) 81.2 K 3.08 K
Total Equity 12.6 18.9 34.8 6.2 (0.4) (1.0)
Total Liabilities and Equity 18.6 24.1 39.0 9.6 0.7 0.8
SHARES OUTSTANDING
Common Shares Outstanding 13.0 11.9 10.2 11.9 11.9 5.9